Bayer Revives Medical AI Patent Application On Appeal
A European appeals panel has rekindled Bayer's hunt for a medical artificial intelligence patent, ruling in a decision made public Wednesday that an earlier decision blocking the application was procedurally flawed....To view the full article, register now.
Already a subscriber? Click here to view full article